89bio, Inc. Annual Income Tax Expense (Benefit) in USD from 2018 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
89bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
- 89bio, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $204K.
- 89bio, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $4.3M.
- 89bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $3.87M, a 20253% increase from 2022.
- 89bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $19K.
- 89bio, Inc. annual Income Tax Expense (Benefit) for 2021 was -$147K, a 149% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)